Down syndrome & childhood leukemia — what parents need to know
Medically reviewed by Dr. Naresh Gundu, Medical Oncologist · Last reviewed June 2026
Children with Down syndrome (trisomy 21) have a higher-than-average chance of developing certain types of leukemia compared to the general population. Understanding this risk helps you ask the right questions, recognise early signs, and get specialist input at the right time — without living in constant fear.
- Most children with Down syndrome do not develop leukemia — but the elevated risk is real and worth monitoring with your paediatrician.
- Early detection is the single most powerful factor — blood count changes found early almost always mean simpler, more effective treatment.
- Down syndrome-associated leukemia responds well to treatment — specialist paediatric oncology care is available at CION Hyderabad.
- You deserve a 45-minute consultation — not a hurried five-minute answer. Our team walks this journey with you.
on Panel
Survival Rate*
Treated
(800+ reviews)
Down syndrome leukemia — why trisomy 21 affects blood cell development
Down syndrome is caused by an extra copy of chromosome 21 — a condition called trisomy 21. That extra chromosome changes how the body’s bone marrow produces blood cells, particularly in foetal development and early infancy. As a result, children with Down syndrome have a meaningfully higher risk of developing leukemia than children in the general population. This does not mean leukemia is inevitable or even likely — but it does mean that staying alert to blood count changes is worthwhile.
The two main types of leukemia associated with trisomy 21 are Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML). In children with Down syndrome, AML tends to be of a specific subtype called Acute Megakaryoblastic Leukaemia (AMKL), which affects the cells that normally go on to form platelets. ALL in children with Down syndrome behaves somewhat differently from ALL in other children — often responding very well to treatment, though with a need for more careful side-effect monitoring.
Before either of those conditions develops, some newborns with Down syndrome experience a pre-leukemic state called Transient Abnormal Myelopoiesis (TAM), sometimes called Transient Myeloproliferative Disorder (TMD). In TAM, abnormal blast cells appear in the blood at birth or in the first few weeks of life. The important thing to know about TAM is that it resolves on its own in the large majority of affected infants. However, a proportion of children who had TAM as newborns later develop AML, usually within the first four years of life. If your newborn was found to have TAM, close follow-up with a paediatric haematologist is essential.
The risk associated with Down syndrome and leukemia has been extensively studied, and this knowledge has directly shaped treatment protocols. Children in this group often respond to lower doses of certain medicines compared to children without Down syndrome — which means treatment can sometimes be gentler while still being highly effective. A paediatric oncologist who is experienced with Down syndrome-associated blood cancers will factor all of this into the treatment plan from day one.
What this means for you as a parent: you do not need to read every blood count yourself, and you should not carry fear of leukemia as a constant background dread. What you can do is keep your child’s paediatric appointments, mention any new symptoms promptly, and know that if a blood count abnormality is ever found, there are specialists ready to guide you with honesty and care. You will never be left with a rushed five-minute conversation. We walk this journey with you.
Signs in your child that should prompt a blood count — trisomy 21 leukemia risk
Most children with Down syndrome will never show any of these signs in the context of leukemia. Every item on this list also has many harmless and common explanations. But if any of the following appear in your child — especially if more than one is present at the same time, or if a single sign persists for more than two to three weeks without a clear cause — please book a visit with your paediatrician and ask for a full blood count (FBC or CBC).
Unusual paleness: Pallor that is new or noticeably worse than usual, particularly around the lips, inside the lower eyelids, or the fingernail beds. This can be a sign that the red blood cell count is low (anaemia), which is common in leukemia because the marrow fills with leukemia cells and cannot produce enough healthy red cells.
Persistent tiredness or low energy: Every child with Down syndrome has their own baseline energy level. If your child seems significantly more tired than usual — sleeping more, less interested in play, or harder to rouse — and it is lasting more than a week or two without a cold or illness to explain it, that is worth a doctor’s review.
Easy bruising or unexplained bruises: Small children bruise on their shins from normal play, but bruises on the trunk, back, or face without a clear injury, or an unusual number of bruises, can reflect low platelet counts (thrombocytopenia).
Petechiae: These are tiny flat red or purple spots on the skin that do not blanch (go white) when you press them. They are caused by small bleeds under the skin from low platelets. Petechiae often appear on the legs, feet, or around the mouth.
Swollen lymph glands that do not go away: Lymph glands in the neck, armpit, or groin that are swollen and have been there for more than three to four weeks — without a recent infection to explain them — deserve evaluation.
Repeated infections that take longer to clear: Because leukemia crowds out the normal white blood cells that fight infection, affected children often have more frequent infections or take much longer than expected to recover from them.
Prolonged fever: A fever that lasts more than five to seven days with no identified infection as its cause should prompt a blood count.
If you are in doubt, do not wait and worry. A full blood count is a simple, fast test. A normal result is genuinely reassuring. An abnormal result — found early — leads to more effective treatment. Either way, you are better informed.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Concerned about your child’s blood counts?
You deserve a clear answer, not a hurried appointment. Our paediatric oncology team gives every family a full 45-minute consultation — tumor board led, transparent, and driven by what is right for your child.
How leukemia is caught early in a child with Down syndrome
If a paediatrician is concerned about a blood count result, this is the sequence of steps that typically follows. Understanding the process in advance means there are fewer surprises — and you can ask better questions at each stage.
Full blood count and blood film
The first test is always a full blood count (FBC or CBC) with a blood film. This is a simple blood draw that measures the levels of red blood cells, white blood cells, and platelets, and looks at the shape and size of those cells under a microscope. An abnormal result — for example, very high or very low white cell counts, anaemia, or low platelets, or the appearance of abnormal cells called blasts in the film — will prompt further investigation. A normal result at this stage is genuinely reassuring and will usually mean monitoring continues at regular intervals rather than any immediate action.
Referral to a paediatric haematologist or oncologist
If the blood count is abnormal in a way that raises concern, your paediatrician will refer your child to a specialist. In Hyderabad, this means a paediatric haematologist or paediatric oncologist experienced in childhood blood cancers. At CION, you will not wait months for this consultation. The team will review your child’s full history, including their Down syndrome diagnosis and any prior TAM, as part of the first assessment. You will be seen as a team — medical, haematology, and if needed paediatric surgical or radiation oncology — and every case goes to our tumor board before any treatment recommendation is made.
Bone marrow aspirate and biopsy
A blood count alone cannot confirm or rule out leukemia. The definitive test is a bone marrow aspirate and biopsy — a procedure that takes a small sample of marrow from the back of the hip bone. In children, this is done under general anaesthesia or deep sedation so your child does not feel the procedure. The marrow is then examined under a microscope (morphology), tested with immunophenotyping to identify the exact type of abnormal cell, and tested for genetic or chromosomal changes that help classify the leukemia and guide the treatment plan. The entire process from sample to results typically takes a few days, depending on the complexity of the tests requested.
Lumbar puncture (spinal fluid check)
A lumbar puncture is usually done at the same time as the bone marrow test — again under sedation — to check whether any leukemia cells have reached the cerebrospinal fluid (the fluid around the brain and spinal cord). This step is standard in leukemia diagnosis because some types of leukemia can spread to the central nervous system, which affects treatment planning. If the spinal fluid is clear of leukemia cells, treatment can be more targeted. If cells are found, the treatment protocol is adjusted accordingly. The procedure itself is brief and your child is asleep throughout.
Tumour board review and treatment planning
Before any treatment begins, every CION paediatric case is reviewed by our multidisciplinary tumour board — a structured meeting of medical oncologists, haematologists, radiation oncologists, paediatric surgeons, and allied care specialists. For a child with Down syndrome and leukemia, this is especially important because the treatment protocol needs to be carefully calibrated: children with trisomy 21 may be more sensitive to certain medicines, and the specific subtype of leukemia (ALL vs. AML-AMKL, or Down syndrome-specific protocols) determines the entire treatment plan. You will receive a clear explanation of the recommended plan, the reasons behind every decision, and the realistic expected timeline before any treatment starts.
Treatment, monitoring, and allied care through every phase
Treatment for leukemia in children with Down syndrome follows the same broad phases as in other children — induction (to achieve remission), consolidation (to eliminate remaining cells), and for ALL, a maintenance phase that continues for one to two years. What differs is the dose adjustment and the more attentive side-effect monitoring that children with Down syndrome need throughout. Allied care — nutritional support, psychological support for your child and your family, and regular developmental review — is part of every CION treatment plan from the very first day, not an afterthought. We do not separate medical treatment from the rest of your child’s wellbeing.
You deserve more than a rushed five minutes
Every family at CION receives a 45-minute consultation — with a team, not just one doctor. Our tumour board reviews every paediatric case before any decision is made. Transparent costs. No unnecessary tests. Decisions for healing, not billing.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Your questions about Down syndrome and leukemia — answered
Does every child with Down syndrome get leukemia?
What type of leukemia is most common in children with Down syndrome?
What is Transient Abnormal Myelopoiesis (TAM) in newborns with Down syndrome?
What blood count changes should I watch for in my child with Down syndrome?
Is leukemia in a child with Down syndrome treated the same way as in other children?
Should my child with Down syndrome have regular blood tests to screen for leukemia?
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.